Odaseva Appoints New Chief Technology Officer

Saddek Dekoum to Support Rapid Expansion of Enterprise Class Data Governance SAN FRANCISCO, CA, November 17, 2020 — Odaseva, the leading Enterprise Cloud Trust Platform for organizations with business-critical cloud deployments, today announced the appointment of Saddek Dekoum as Chief Technology Officer. Dekoum offers Odaseva more than 20 years of experience in research and development.… Read More »

HIV is an independent risk factor for smoking-related cancers, especially in women

New research provides compelling evidence that infection with HIV is an independent risk factor for developing smoking-related cancers. Published in AIDS, the study’s findings are especially important because they compared cancer-risk between closely-matched individuals with and without HIV who were enrolled in long-standing cohort studies. Women with HIV appeared to have an especially high risk… Read More »

The Secret to Raising Smart Kids

More than three decades of scientific research suggests that repeatedly telling children that they are especially smart or talented leaves them vulnerable to failure, and fearful of challenges. Children raised this way develop an implicit belief that intelligence is innate and fixed, making striving to learn seem less important than seeming smart; challenges, mistakes, and… Read More »

Is Alzheimer’s a Form of Diabetes?

More evidence has been uncovered that Alzheimer’s disease may actually be a third form of diabetes, according to researchers from Northwestern University. Insulin and insulin receptors in your brain are crucial for learning and memory, and it’s known that these components are lower in people with Alzheimer’s disease. In your brain, insulin binds to an… Read More »

Controversial Alzheimer’s Drug Faces Critical Test Before F.D.A. Panel

A federal panel will decide on Friday whether to recommend approval of a controversial but potentially promising Alzheimers drug, which would be the first to come to market in nearly two decades. The drug, aducanumab, would not stop or reverse dementia, but some evidence suggests it can slow the progression of memory and thinking problems… Read More »